|Mr. Scott M. Langille||Chief Financial Officer||N/A||N/A||1957|
|Mr. Matthew McLeod||CEO, Pres & Director||N/A||N/A||N/A|
|Dr. James Hyssen||Chief Operating Officer||N/A||N/A||N/A|
|Dr. Steven Prescott Bennett||Chief Scientific Officer||N/A||N/A||N/A|
|Shawn Alexander||VP of Investor Relations||N/A||N/A||N/A|
Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada. Wayland Group Corp. is a subsidiary of Maricann Group Inc.
Wayland Group Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.